Ana Tadijan

10PUBLICATIONS

19CO-AUTHORS

Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targetsBiologically active moleculesCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 26, 2026

The p53 Isoforms as Potential Biomarkers in Different Cancer Entities.

|Sep 14, 2024

Mitochondrial NME6 Influences Basic Cellular Processes in Tumor Cells In Vitro.

Bastien Proust, Anđela Horvat, Ana Tadijan

|Jan 08, 2023

p53 Family in Resistance to Targeted Therapy of Melanoma.

Ignacija Vlašić, Anđela Horvat, Ana Tadijan

|Oct 27, 2022

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions.

Ana Tadijan, Ignacija Vlašić, Josipa Vlainić

|Sep 09, 2022

Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.

Martina Radić, Ignacija Vlašić, Maja Jazvinšćak Jembrek

|Oct 23, 2021

Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness.

Ana Tadijan, Francesca Precazzini, Nikolina Hanžić

Pageof 2

Frequent Collaborators

6 joint publications

Ignacija Vlašić

4 joint publications

Anđela Horvat

3 joint publications

Maja Jazvinšćak Jembrek

2 joint publications

Iva I Podgorski

2 joint publications

Marijana Popović Hadžija

Mladen Paradžik

Sandra Sobočanec

Jonathan D Humphries

Martin J Humphries

Martina Deželjin

Frequent Collaborators

6 joint publications

Ignacija Vlašić

4 joint publications

Anđela Horvat

3 joint publications

Maja Jazvinšćak Jembrek

2 joint publications

Iva I Podgorski